| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 公司成立于2000年，是中国医药装备行业的领军企业，也是世界医药装备行业的知名企业之一。主营业务系医药装备及其整体技术解决方案，并率先推动智慧医药工厂的研究与开发。公司系中国A股上市公司。旗下拥有德国ROMACO集团、楚天华通、四川省医药设计院、楚天飞云、楚天源创、楚天微球、楚天思优特、楚天思为康、楚天华兴、楚天长兴、楚天科仪、楚天净邦、楚天派特、楚天博源、楚天智能机器人等多家全资或控股子公司，全球员工总数9000余人，总资产110亿元。公司已有长沙和德国两大运营总部，建有长沙中央技术研究院、欧洲技术研究院和四川省医药设计院三大研发机构。设有国家级企业技术中心，国家级创新基地，博士后科研工作站，院士专家工作站等多个技术与创新平台。截止2023年10月31日，共提出5250项中国专利申请，授权专利4241项，有效专利3121项。另提出50件PCT国际专利申请，在美国、俄罗斯、印度、韩国、德国、印尼、日本、欧洲等多国获得25项专利授权。牵头制订了本系统国家行业产品技术标准20多项。集团产品与服务已累计覆盖180多个国家和地区，国际市场占有率正逐年快速提升。公司正在全力打造“楚天生物医药与生命科学产业链”，进入了生物医药高分子材料领域和生命科学基因技术领域，正在朝着千亿产业链目标疾速推进。公司坚持“做受尊敬的人、造受尊敬的产品、办受尊敬的企业”的核心价值观，弘扬“因为执着，所以卓越”的精神，落实“以客户为中心、以奋斗者为本、以目标责任结果为导向”的经营宗旨，履行“让世界制药工业插上智慧的翅膀”之使命，争取在2030年前后将楚天打造成为全球医药装备行业领军企业之一。 | ||||||||||||||||||||||||
| Main Business | 水剂类制药装备的研发、设计、生产、销售和服务。 | ||||||||||||||||||||||||
| Legal Representative | 唐岳 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 周飞跃 | ||||||||||||||||||||||||
| Solicitors | 湖南启元律师事务所 | ||||||||||||||||||||||||
| Auditors | 中审众环会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0731-87938288;0731-87938220 | ||||||||||||||||||||||||
| Fax No | 0731-87938211 | ||||||||||||||||||||||||
| Website | www.truking.cn | ||||||||||||||||||||||||
| truking@truking.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 21/01/2014 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.547 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.100 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 7.996 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 4.941B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |